Cyclotide-membrane Interactions: Defining Factors of Membrane Binding, Depletion and Disruption
Overview
Biophysics
Affiliations
The cyclotide family of plant-derived peptides is defined by a cyclic backbone and three disulfide bonds locked into a cyclic cystine knot. They display a diverse range of biological activities, many of which have been linked to an ability to target biological membranes. In the current work, we show that membrane binding and disrupting properties of prototypic cyclotides are dependent on lipid composition, using neutral (zwitterionic) membranes with or without cholesterol and/or anionic lipids. Cycloviolacin O2 (cyO2) caused potent membrane disruption, and showed selectivity towards anionic membranes, whereas kalata B1 and kalata B2 cyclotides were significantly less lytic towards all tested model membranes. To investigate the role of the charged amino acids of cyO2 in the membrane selectivity, these were neutralized using chemical modifications. In contrast to previous studies on the cytotoxic and antimicrobial effects of these derivatives, the Glu6 methyl ester of cyO2 was more potent than the native peptide. However, using membranes of Escherichia coli lipids gave the opposite result: the activity of the native peptide increased 50-fold. By using a combination of ellipsometry and LC-MS, we demonstrated that this unusual membrane specificity is due to native cyO2 extracting preferentially phosphatidylethanolamine-lipids from the membrane, i.e., PE-C16:0/cyC17:0 and PE-C16:0/C18:1.
Shirsat H, Datt M, Kale A, Mishra M ACS Omega. 2025; 10(8):7583-7596.
PMID: 40060863 PMC: 11886644. DOI: 10.1021/acsomega.4c11339.
Small and Versatile Cyclotides as Anti-infective Agents.
Candido E, Gasparetto L, Luchi L, Pimentel J, Cardoso M, Macedo M ACS Infect Dis. 2025; 11(2):386-397.
PMID: 39842000 PMC: 11833872. DOI: 10.1021/acsinfecdis.4c00957.
Analysis of Natural Plant-Derived Cyclotides with Antifungal Activity against Pathogenic Fungi.
Sharma A, Butool B, Sahu P, Mishra R, Mohanty A Protein Pept Lett. 2024; 31(3):247-260.
PMID: 38445693 DOI: 10.2174/0109298665295545240223114346.
Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro.
Melander E, Eriksson C, Wellens S, Hosseini K, Fredriksson R, Gosselet F Pharmaceutics. 2023; 15(5).
PMID: 37242750 PMC: 10222203. DOI: 10.3390/pharmaceutics15051507.
Rajendran S, Slazak B, Mohotti S, Muhammad T, Stromstedt A, Kapusta M J Nat Prod. 2022; 86(1):52-65.
PMID: 36525646 PMC: 9887600. DOI: 10.1021/acs.jnatprod.2c00674.